Literature DB >> 19750306

Effects on mother and fetus of epidural and combined spinal-epidural techniques for labor analgesia.

Giane Nakamura1, Eliana Marisa Ganem, Ligia Maria Suppo de Souza Rugolo, Yara Marcondes Machado Castiglia.   

Abstract

OBJECTIVE: Epidural (EA) and combined spinal-epidural (CSE) techniques have both been utilized for labor analgesia. This study compared the effects on the mother and newborn of these techniques in labor analgesia and anesthesia.
METHODS: Forty pregnant women received epidural analgesia with 15 mL of 0.125% ropivacaine (EA group) and 5 microg of sufentanil plus 2.5mg bupivacaine in the subarachnoid space (CSE group). Pain intensity, sensory blockade level, latency time, motor block intensity, labor analgesia duration, epidural analgesia duration, maternal hypotension, and pruritus were evaluated. The newborns were evaluated by Apgar and the neurological and adaptive capacity score (NACS) developed by Amiel-Tison.
RESULTS: There were no significant statistical differences between groups for pain scores, latency time, sensory blockade level, and Apgar score. Motor block, labor analgesia duration, and epidural analgesia duration were greater in the CSE group, whose seven mothers had mild pruritus. The NACS were greater in the EA group after half, two, and 24 hours. Ninety five percent of EA group newborns and 60% of CSE group newborns were found to be neurologically healthy at the 24 hour examination.
CONCLUSION: EA and CSE analgesia relieved maternal pain during obstetric analgesia, but CSE mothers had pruritus and a longer labor. Newborns of mothers who received epidural analgesia showed the best NACS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19750306     DOI: 10.1590/s0104-42302009000400014

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  8 in total

Review 1.  Combined spinal-epidural versus epidural analgesia in labour.

Authors:  Scott W Simmons; Neda Taghizadeh; Alicia T Dennis; Damien Hughes; Allan M Cyna
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

2.  Comparative evaluation of epidural bupivacaine - dexmedetomidine and bupivacaine -fentanyl on Doppler velocimetry of uterine and umbilical arteries during labor.

Authors:  Mohamed Fouad Selim; Ali Mohamed Ali Elnabtity; Ali Mohamed Ali Hasan
Journal:  J Prenat Med       Date:  2012-07

3.  Comparative study of fentanyl and morphine in addition to hyperbaric or isobaric bupivacaine in combined spinal anaesthesia for caesarean section.

Authors:  Ayten Saracoglu; Kemal T Saracoglu; Zeynep Eti
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

4.  Effects of intrathecal hyperbaric ropivacaine versus hyperbaric bupivacaine for lower limb orthopedic surgery.

Authors:  Somjit Chatterjee; Bikash Bisui; Anamitra Mandal; Jagabandhu Sheet; Swapnadeep Sengupta; Shakya Majumdar; Sarbari Swaika
Journal:  Anesth Essays Res       Date:  2014 Sep-Dec

5.  Comparing Effects of Intrathecal Adjuvants Fentanyl and Dexmedetomidine with Hyperbaric Ropivacaine in Patients Undergoing Elective Infraumbilical Surgeries: A Prospective, Double-Blind, Clinical Study.

Authors:  T K Shashikala; Sachinkumar S Sagar; Puttaiah Ramaliswamy; Vinod V Hudgi
Journal:  Anesth Essays Res       Date:  2019-12-16

6.  Comparison Between the Use of Ropivacaine Alone and Ropivacaine With Sufentanil in Epidural Labor Analgesia.

Authors:  Xian Wang; Shiqin Xu; Xiang Qin; Xiaohong Li; Shan-Wu Feng; Yusheng Liu; Wei Wang; Xirong Guo; Rong Shen; Xiaofeng Shen; Fuzhou Wang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

7.  Comparison of ropivacaine combined with sufentanil for epidural anesthesia and spinal-epidural anesthesia in labor analgesia.

Authors:  Yanshuang Wang; Mingjun Xu
Journal:  BMC Anesthesiol       Date:  2020-01-02       Impact factor: 2.217

8.  Adjuvant Sufentanil Decreased the EC50 of Epidural Ropivacaine for Labor Analgesia in Healthy Term Pregnancy.

Authors:  Bo Xiang; Jian Yang; Xiaofeng Lei; Jin Yu
Journal:  Drug Des Devel Ther       Date:  2021-05-18       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.